Ahmed Daak

Corporate Officer/Principal presso International Society for the Study of Fatty Acids & Lipids

Consumer Services

Commercial Services

Posizioni attive di Ahmed Daak

Società	Posizione	Inizio	Fine
International Society for the Study of Fatty Acids & Lipids	Corporate Officer/Principal	-	-

Società	Posizione	Inizio	Fine
University of Khartoum	Corporate Officer/Principal	-	-
Sancilio Pharmaceuticals Co., Inc. Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL.	Direttore Tecnico/Scientifico/R&S	01/07/2015	-

University of London

Doctorate Degree

Distribuzione geografica

Posizioni

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Settori

Consumer Services	3
Commercial Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
Sancilio Pharmaceuticals Co., Inc. Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL.	Commercial Services
International Society for the Study of Fatty Acids & Lipids

Aziende private

Commercial Services

International Society for the Study of Fatty Acids & Lipids